Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma

Author:

Lee Chee Khoon12,Man Johnathan2,Lord Sally13,Cooper Wendy456,Links Matthew2,Gebski Val1,Herbst Roy S.78,Gralla Richard J.910,Mok Tony11,Yang James Chih-Hsin1213

Affiliation:

1. National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia

2. Cancer Care Centre, St George Hospital, Sydney, New South Wales, Australia

3. School of Medicine, The University of Norte Dame, Sydney, New South Wales, Australia

4. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

5. Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

6. School of Medicine, Western Sydney University, Sydney, New South Wales, Australia

7. Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut

8. Smilow Cancer Hospital, New Haven, Connecticut

9. Department of Medicine (Oncology), Albert Einstein College of Medicine, New York, New York

10. Hematology-Oncology Division, Jacobi Medical Center, New York, New York

11. Hong Kong Cancer Institute, Department of Clinical Oncology, Chinese University of Hong Kong, Shatin, China

12. Graduate Institute of Oncology, National Taiwan University, Taipei City, Taiwan

13. Department of Oncology, National Taiwan University Hospital, Taipei City, Taiwan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3